Targeting one-carbon metabolism by methyl donors for prevention of non-alcoholic fatty liver in rats

被引:0
|
作者
Al Doghaither, Huda Abdulaziz [1 ]
机构
[1] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia
来源
关键词
One-Carbon Metabolism; L-Methionine; Choline; Folic Acid; Methyl Donors; BIOMARKERS; DISEASE;
D O I
10.4328/ACAM.21802
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The purpose of the current work was to demonstrate and compare the impacts of folate, methionine, and choline as methyl donors in the prevention of NAFLD induced by a high-fructose diet (HFrD). Material and Methods: Sixty adult male albino rats were divided into five groups: G1 had a control-fed basal diet; in G2, the rats were fed an HFrD containing 45% fructose (HFrD); in G3, G4, and G5, the rats were fed an HFrD supplemented with folic acid, L-methionine, and choline chloride, respectively. The present study's findings showed a close connection between methyl donors and lipid metabolism. Results: The findings indicated that the folic acid supplemented diet (HFrD+ folate) exhibited the most substantial improvement in hepatic total lipids (TP), triacylglycerol (TG), phospholipid (PL), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), free fatty acid (FFA), albumin (ALB), total bile acid (TBA), fasting blood glucose (FBG), proinflammatory cytokines levels, and enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), fatty acid synthase (FAS), and acetyl coenzyme A carboxylase (ACC). In the same context, L-methionine had the most significant improvement in oxidative stress biomarker (glutathione [GSH], superoxide dismutase [SOD], 4-hydroxynonenal [4-HNE]) levels, followed by folic acid and choline. Discussion: Methyl donors such as folic acid, methionine, and choline are essential for maintaining OCM and can prevent animals with NAFLD from developing liver lipid accumulation.
引用
收藏
页码:830 / 834
页数:5
相关论文
共 50 条
  • [31] Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
    Zhang, Lijia
    Dai, Xuezheng
    Wang, Li
    Cai, Jingming
    Shen, Jie
    Shen, Yang
    Li, Xianan
    Zhao, Yan
    FRONTIERS IN NUTRITION, 2022, 9
  • [32] Non-alcoholic fatty liver and cancer
    Ajit Venniyoor
    Indian Journal of Gastroenterology, 2020, 39 : 303 - 303
  • [33] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [34] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [35] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [36] Non-alcoholic Fatty Liver Diseases
    Roeb, Elke
    Steffen, Hans-Michael
    Bojunga, Joerg
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (24) : 1846 - 1846
  • [37] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [38] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [39] Non-alcoholic fatty liver and cancer
    Venniyoor, Ajit
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2020, 39 (03) : 303 - 303
  • [40] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15